Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Kalil, Andre C ^a   Florescu, Diana F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CANCER PATIENT; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; GRAFT RECIPIENT; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; NOTE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEPSIS; STATISTICAL ANALYSIS; VIRUS REACTIVATION; CYTOMEGALOVIRUS; MALE; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; MALE; SEPSIS; VIRUS ACTIVATION;

EID: 84055195500     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10093     Document Type: Note

References (9)

1. Heininger A, Haeberle HA, Fischer I, Beck R, Riessen R, Rohde F, Meisner C, Jahn G, Koenigsrainer A, Unertl K, Hamprecht K. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011, 15:R77. 10.1186/cc10069, 21362193.
2. Stanberry LR, Rosenthal SL, Mills L, Succop PA, Biro FM, Morrow RA, Bernstein DI. Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis 2004, 39:1433-1438. 10.1086/425307, 15546077.
3. Lubeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed?. Med Microbiol Immunol 2010, 199:53-60. 10.1007/s00430-009-0136-3, 19949960.
4. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect 2009, 137:58-65. 10.1017/S0950268808000551, 18413004.
5. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
6. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96. 10.1097/00024382-200116020-00001, 11508871.
7. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009, 37:2350-2358. 10.1097/CCM.0b013e3181a3aa43, 19531944.
8. Kalil AC, Sun J, Florescu DF. The importance of detecting cytomegalovirus infections in studies evaluating new therapies for severe sepsis. Crit Care Med 2010, 38(10 Suppl):S663-S667. 10.1097/CCM.0b013e3181f20319, 21164412.
9. Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, Allardet-Servent J, Gainnier M, Zandotti C, Papazian L. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009, 37:1850-1857. 10.1097/CCM.0b013e31819ffea6, 19384219.